Lupin Ltd

  • BSE Code : 500257
  • NSE Symbol : LUPIN
  • ISIN : INE326A01037
  • Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

up-arrow 1,660.30 8.55(0.52%)

Open Price ()

1,652.00

Prev. Close ()

1,651.75

Volume (No’s)

42,384

Market Cap ()

75,668.19

Low Price ()

1,648.60

High Price ()

1,666.00

 

Corporate Announcement

17-May-2024 Lupin Limited - Loss of Share Certificates
15-May-2024 Lupin Limited - Disclosure under SEBI Takeover Regulations
14-May-2024 Lupin Limited - Analysts/Institutional Investor Meet/Con. Call Updates
13-May-2024 Lupin Limited - ESOP/ESOS/ESPS
10-May-2024 Lupin Limited - Updates

Stock Summary

Market Cap(₹Cr.)

75,652.24

P/E (TTM)

32.52

Book value ()

452.07

Div Yield (%)

0.48

EPS (TTM)

51.04

Face Value ()

2.00

Technical Analysis

Key Level

Resistance 1

1,675.92

Resistance 2

1,700.08

Support 1

1,632.92

Support 2

1,614.08

Moving Average

30 Days

1,617.89

50 Days

1,622.01

100 Days

1,551.12

200 Days

1,352.02

Peers Group

Company Market Cap (₹in Cr.) P/E (x) P/B(x) EV / EBITDA(x) Dividend Yield(%) EPS
Lupin Ltd 75,652.24 32.52 1.6 1173.92 0.48 51.04
Sun Pharmaceuticals Indus.. 367,290.20 89.16 9.93 3814.1 0.75 17.17
Cipla Ltd 113,350.18 30.52 2.95 4107.41 0.61 46
Zydus Lifesciences Ltd 111,133.51 41.35 3.65 2799 0.27 26.71
Divis Laboratories Ltd 104,234.91 76.42 5.9 2697.86 0.76 51.38

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made investment of

in Months Ago

My investment would be worth 95,664.50 with a Loss of -4.34%

Share Holding

CATEGORY NO. OF SHARES PERCENTAGE (%)
Total Foreign 85215771 18.70
Total Institutions 126517544 27.76
Total Govt Holding 39584 0.01
Total Non Promoter Corporate Holding 1785689 0.39
Total Promoters 214204744 47.01
Total Public & others 27915576 6.13
Total 455678908 100
  • Total Foreign
  • Total Institutions
  • Total Govt Holding
  • Total Non Promoter Corporate Holding
  • Total Promoters
  • Total Public & others

Corporate Actions

About Company

Lupin is an innovation led Transnational Pharmaceutical Company producing, developing and marketing a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The Company has significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, Central Nervous System (CNS), Gastro-Intestinal (GI), Anti-Infective and Nonsteroidal Anti Inflammatory Drug (NSAID) therapy segments and is a global leader in the Anti-TB and Cephalosporins segments.

Lupin Ltd was incorporated in the year 1983 with the name Lupin Chemicals Ltd. In the year 1987, the company commenced operations in Cephalexin Plant at Mandideep and 7 ADCA plant at Ankleshwar. In the year 1989, the company established a joint venture in Thailand, namely Lupin Chemicals (Thailand) Ltd. In the year 1991, they initiated production of Injectable cephalosporin (bulk and dosages) at Mandideep. In the year 1992, the company set up Fermentation Plant at Tarapur, Maharashtra. Also, Sterile Plant for injectable Cephalosporins (bulk) was commissioned at Mandideep.

In the year 2001, Lupin Laboratories Ltd was amalgamated with the company and the name was changed to Lupin Ltd. They commenced supply of Cephalosporin bulk actives to their alliance partners in the...

Copyright © 2019 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)